Literature DB >> 11701732

Aberrant membrane hormone receptors in incidentally discovered bilateral macronodular adrenal hyperplasia with subclinical Cushing's syndrome.

I Bourdeau1, P D'Amour, P Hamet, J M Boutin, A Lacroix.   

Abstract

Cortisol secretion in adrenal Cushing's syndrome can be regulated by the aberrant adrenal expression of receptors for gastric inhibitory polypeptide, vasopressin, catecholamines, LH/human CG (LH/hCG), or serotonin. Four patients with incidentally discovered bilateral macronodular adrenal hyperplasia without clinical Cushing's syndrome were evaluated for the possible presence of aberrant adrenocortical hormone receptors. Urinary free cortisol levels were within normal limits, but plasma cortisol levels were slightly elevated at nighttime and suppressed incompletely after dexamethasone administration. Plasma ACTH was partially suppressed basally but increased after administration of ovine CRH. A 51-yr-old woman had ACTH-independent increases of plasma cortisol after 10 IU AVP im (292%), 100 microg GnRH iv (184%), or 10 mg cisapride orally (310%); cortisol also increased after administration of NaCl (3%), hCG, human LH, and metoclopramide. In a 61-yr-old man, cortisol was increased by AVP (349%), GnRH (155%), hCG (252%), and metoclopramide (191%). Another 53-yr-old male increased plasma cortisol after AVP (171%) and cisapride (142%). Cortisol secretion was also stimulated by vasopressin in a 54-yr-old female. This study demonstrates that subclinical secretion of cortisol can be regulated via the aberrant function of at least V1-vasopressin, LH/hCG, or 5-HT4 receptors in incidentally identified bilateral macronodular adrenal hyperplasia.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11701732     DOI: 10.1210/jcem.86.11.8062

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  20 in total

1.  Inherited adrenocorticotropin-independent macronodular adrenal hyperplasia with abnormal cortisol secretion by vasopressin and catecholamines: detection of the aberrant hormone receptors on adrenal gland.

Authors:  Nobuhiro Miyamura; Tetsuya Taguchi; Yusuke Murata; Kayo Taketa; Shinsuke Iwashita; Kazuya Matsumoto; Takeshi Nishikawa; Tetsushi Toyonaga; Michiharu Sakakida; Eiichi Araki
Journal:  Endocrine       Date:  2002-12       Impact factor: 3.633

2.  A case of ACTH-independent bilateral macronodular adrenal hyperplasia and severe congestive heart failure.

Authors:  D Suri; M Alonso; R E Weiss
Journal:  J Endocrinol Invest       Date:  2006-11       Impact factor: 4.256

3.  The role of adrenal scintigraphy in the diagnosis of subclinical Cushing's syndrome and the prediction of post-surgical hypoadrenalism.

Authors:  Maria Pia Ricciato; Vincenzo Di Donna; Germano Perotti; Alfredo Pontecorvi; Rocco Bellantone; Salvatore M Corsello
Journal:  World J Surg       Date:  2014-06       Impact factor: 3.352

4.  Do patients with incidentally discovered bilateral adrenal nodules represent an early form of ARMC5-mediated bilateral macronodular hyperplasia?

Authors:  Holly Emms; Ioanna Tsirou; Treena Cranston; Stylianos Tsagarakis; Ashley B Grossman
Journal:  Endocrine       Date:  2016-06-15       Impact factor: 3.633

Review 5.  Aberrant expression of hormone receptors in adrenal Cushing's syndrome.

Authors:  Stavroula Christopoulos; Isabelle Bourdeau; André Lacroix
Journal:  Pituitary       Date:  2004       Impact factor: 4.107

6.  ARMC5 Mutations in a Large Cohort of Primary Macronodular Adrenal Hyperplasia: Clinical and Functional Consequences.

Authors:  Stéphanie Espiard; Ludivine Drougat; Rossella Libé; Guillaume Assié; Karine Perlemoine; Laurence Guignat; Gaelle Barrande; Françoise Brucker-Davis; Françoise Doullay; Stephanie Lopez; Emmanuel Sonnet; Florence Torremocha; Denis Pinsard; Nathalie Chabbert-Buffet; Marie-Laure Raffin-Sanson; Lionel Groussin; Françoise Borson-Chazot; Joël Coste; Xavier Bertagna; Constantine A Stratakis; Felix Beuschlein; Bruno Ragazzon; Jérôme Bertherat
Journal:  J Clin Endocrinol Metab       Date:  2015-04-08       Impact factor: 5.958

7.  Successful Treatment of Estrogen Excess in Primary Bilateral Macronodular Adrenocortical Hyperplasia with Leuprolide Acetate.

Authors:  Fady Hannah-Shmouni; Andreas G Moraitis; Vladimir Valera Romero; Fabio R Faucz; Spyridon A Mastroyannis; Annabel Berthon; Richard A Failor; Maria Merino; Andrew P Demidowich; Constantine A Stratakis
Journal:  Horm Metab Res       Date:  2017-11-28       Impact factor: 2.936

Review 8.  The pathogenic role of the GIP/GIPR axis in human endocrine tumors: emerging clinical mechanisms beyond diabetes.

Authors:  Daniela Regazzo; Mattia Barbot; Carla Scaroni; Nora Albiger; Gianluca Occhi
Journal:  Rev Endocr Metab Disord       Date:  2020-03       Impact factor: 6.514

9.  ARMC5 mutations in macronodular adrenal hyperplasia with Cushing's syndrome.

Authors:  Guillaume Assié; Rossella Libé; Stéphanie Espiard; Marthe Rizk-Rabin; Anne Guimier; Windy Luscap; Olivia Barreau; Lucile Lefèvre; Mathilde Sibony; Laurence Guignat; Stéphanie Rodriguez; Karine Perlemoine; Fernande René-Corail; Franck Letourneur; Bilal Trabulsi; Alix Poussier; Nathalie Chabbert-Buffet; Françoise Borson-Chazot; Lionel Groussin; Xavier Bertagna; Constantine A Stratakis; Bruno Ragazzon; Jérôme Bertherat
Journal:  N Engl J Med       Date:  2013-11-28       Impact factor: 91.245

10.  Clinical and genetic heterogeneity, overlap with other tumor syndromes, and atypical glucocorticoid hormone secretion in adrenocorticotropin-independent macronodular adrenal hyperplasia compared with other adrenocortical tumors.

Authors:  Hui-Pin Hsiao; Lawrence S Kirschner; Isabelle Bourdeau; Margaret F Keil; Sosipatros A Boikos; Somya Verma; Audrey J Robinson-White; Maria Nesterova; André Lacroix; Constantine A Stratakis
Journal:  J Clin Endocrinol Metab       Date:  2009-06-09       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.